| Product Code: ETC4664320 | Publication Date: Nov 2023 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The market for antidiabetics import shipments in Brunei continues to be dominated by key exporting countries such as Malaysia, Singapore, Ireland, USA, and Australia. The high concentration levels observed in 2023 escalated to very high levels in 2024, indicating a competitive landscape with limited diversification. The negative Compound Annual Growth Rate (CAGR) of -12.13% over the period 2020-24, coupled with a declining growth rate of -5.61% from 2023 to 2024, suggests a challenging market environment for antidiabetics imports in Brunei. Stakeholders should closely monitor these trends to make informed business decisions.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Brunei Antidiabetics Market Overview |
3.1 Brunei Country Macro Economic Indicators |
3.2 Brunei Antidiabetics Market Revenues & Volume, 2021 & 2031F |
3.3 Brunei Antidiabetics Market - Industry Life Cycle |
3.4 Brunei Antidiabetics Market - Porter's Five Forces |
3.5 Brunei Antidiabetics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Brunei Antidiabetics Market Revenues & Volume Share, By Patient Population, 2021 & 2031F |
3.7 Brunei Antidiabetics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Brunei Antidiabetics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Brunei Antidiabetics Market Trends |
6 Brunei Antidiabetics Market Segmentations |
6.1 Brunei Antidiabetics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Brunei Antidiabetics Market Revenues & Volume, By Insulin? , 2021-2031F |
6.1.3 Brunei Antidiabetics Market Revenues & Volume, By Drug Class, 2021-2031F |
6.2 Brunei Antidiabetics Market, By Patient Population |
6.2.1 Overview and Analysis |
6.2.2 Brunei Antidiabetics Market Revenues & Volume, By Pediatric, 2021-2031F |
6.2.3 Brunei Antidiabetics Market Revenues & Volume, By Adult, 2021-2031F |
6.2.4 Brunei Antidiabetics Market Revenues & Volume, By Geriatric, 2021-2031F |
6.3 Brunei Antidiabetics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Brunei Antidiabetics Market Revenues & Volume, By Insulin syringe/ Insulin pen, 2021-2031F |
6.3.3 Brunei Antidiabetics Market Revenues & Volume, By Insulin pump, 2021-2031F |
6.3.4 Brunei Antidiabetics Market Revenues & Volume, By Intravenous infusion, 2021-2031F |
6.3.5 Brunei Antidiabetics Market Revenues & Volume, By Oral, 2021-2031F |
6.3.6 Brunei Antidiabetics Market Revenues & Volume, By Others, 2021-2031F |
7 Brunei Antidiabetics Market Import-Export Trade Statistics |
7.1 Brunei Antidiabetics Market Export to Major Countries |
7.2 Brunei Antidiabetics Market Imports from Major Countries |
8 Brunei Antidiabetics Market Key Performance Indicators |
9 Brunei Antidiabetics Market - Opportunity Assessment |
9.1 Brunei Antidiabetics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Brunei Antidiabetics Market Opportunity Assessment, By Patient Population, 2021 & 2031F |
9.3 Brunei Antidiabetics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Brunei Antidiabetics Market - Competitive Landscape |
10.1 Brunei Antidiabetics Market Revenue Share, By Companies, 2024 |
10.2 Brunei Antidiabetics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |